Postprandial superior mesenteric artery blood flow increase

1. Acarbose decreases postprandial superior mesenteric artery blood flow increase in humans (from 496.80±147.15 to 374.55±97.89 ml/min (P=0.031)).

   “the increase of postprandial SMA blood flow from 496.80±147.15 to 374.55±97.89 ml/min (P=0.031)”

   Human trialpostprandial hypotension concomitant with abnormal glucose metabolism50 mgn = 20

   Acarbose, the α-glucosidase inhibitor, attenuates the blood pressure and splanchnic blood flow responses to meal in elderly patients with postprandial hypotension concomitant with abnormal glucose metabolism

   Blood pressure monitoring·1 Feb 2016

More on Acarbose